<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34504168</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>12</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>12</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Sep</Month><Day>09</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Prognostic prediction by hypermetabolism varies depending on the nutritional status in early amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>17943</StartPage><MedlinePgn>17943</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">17943</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-021-97196-5</ELocationID><Abstract><AbstractText>To examine whether hypermetabolism could predict the prognosis of early amyotrophic lateral sclerosis (ALS) patients with differing nutritional profiles. This single-center, retrospective study examined the prognosis of ALS patients with hypermetabolism in relation to their nutritional status at hospitalization. The metabolic state was estimated by the ratio of measured resting energy expenditure (mREE) to lean soft tissue mass (LSTM) (mREE/LSTM), wherein patients with ratios&#x2009;&#x2265;&#x2009;38 were defined as hypermetabolic. Malnutrition was defined as %ideal body weight&#x2009;&lt;&#x2009;0.9. Forty-eight patients were enrolled in this study. The hypermetabolic group had shorter survival in the normal-weight group but more prolonged survival in the malnutrition group. Multiplication of nutritional and metabolic factors, such as [(body mass index (BMI)&#x2009;-&#x2009;19.8)&#x2009;&#xd7;&#x2009;(mREE/LSTM&#x2009;-&#x2009;38)], designated as BMI-muscle metabolism index (BMM index), successfully predicted the prognosis in the group with a high BMM index (&#x2265;&#x2009;1), which showed shorter survival and a faster rate of weight loss and functional decline. Multivariate analysis using the Cox model showed high BMM index was an independent poor prognostic factor (hazard ratio: 4.05; p&#x2009;=&#x2009;0.025). Prognostic prediction by hypermetabolism varies depending on the nutritional status in ALS, and the BMM index is a consistent prognostic factor.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nakamura</LastName><ForeName>Ryutaro</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Shiga University of Medical Science, Seta-Tsukinowa-cho, Otsu, Shiga, 520-2192, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurihara</LastName><ForeName>Mika</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Clinical Nutrition, Shiga University of Medical Science, Seta-Tsukinowa-cho, Otsu, Shiga, 520-2192, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogawa</LastName><ForeName>Nobuhiro</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, Shiga University of Medical Science, Seta-Tsukinowa-cho, Otsu, Shiga, 520-2192, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kitamura</LastName><ForeName>Akihiro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Shiga University of Medical Science, Seta-Tsukinowa-cho, Otsu, Shiga, 520-2192, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamakawa</LastName><ForeName>Isamu</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Neurology, Shiga University of Medical Science, Seta-Tsukinowa-cho, Otsu, Shiga, 520-2192, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bamba</LastName><ForeName>Shigeki</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Clinical Nutrition, Shiga University of Medical Science, Seta-Tsukinowa-cho, Otsu, Shiga, 520-2192, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanada</LastName><ForeName>Mitsuru</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Shiga University of Medical Science, Seta-Tsukinowa-cho, Otsu, Shiga, 520-2192, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sasaki</LastName><ForeName>Masaya</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Clinical Nutrition, Shiga University of Medical Science, Seta-Tsukinowa-cho, Otsu, Shiga, 520-2192, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Urushitani</LastName><ForeName>Makoto</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Shiga University of Medical Science, Seta-Tsukinowa-cho, Otsu, Shiga, 520-2192, Japan. uru@belle.shiga-med.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008077">Lipoproteins, LDL</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001823" MajorTopicYN="N">Body Composition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002153" MajorTopicYN="N">Calorimetry, Indirect</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004734" MajorTopicYN="Y">Energy Metabolism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008077" MajorTopicYN="N">Lipoproteins, LDL</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044342" MajorTopicYN="N">Malnutrition</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009752" MajorTopicYN="Y">Nutritional Status</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34504168</ArticleId><ArticleId IdType="pmc">PMC8429558</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-97196-5</ArticleId><ArticleId IdType="pii">10.1038/s41598-021-97196-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chi&#xf2; A, et al. Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: A population-based study. JAMA Neurol. 2014;71:1134&#x2013;1142. doi: 10.1001/jamaneurol.2014.1129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2014.1129</ArticleId><ArticleId IdType="pubmed">25048026</ArticleId></ArticleIdList></Reference><Reference><Citation>Shepheard SR, et al. Value of systematic genetic screening of patients with amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2021 doi: 10.1136/jnnp-2020-325014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-325014</ArticleId><ArticleId IdType="pmc">PMC8053339</ArticleId><ArticleId IdType="pubmed">33589474</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu CH, et al. Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosis. Neurol. Neuroimmunol. Neuroinflamm. 2016;3:e244. doi: 10.1212/NXI.0000000000000244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000244</ArticleId><ArticleId IdType="pmc">PMC4897985</ArticleId><ArticleId IdType="pubmed">27308305</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferri A, Coccurello R. What is &#x201c;Hyper&#x201d; in the ALS hypermetabolism? Mediat. Inflamm. 2017;2017:7821672. doi: 10.1155/2017/7821672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/7821672</ArticleId><ArticleId IdType="pmc">PMC5610793</ArticleId><ArticleId IdType="pubmed">29081604</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandrioli J, et al. Proteostasis and ALS: Protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS) BMJ Open. 2019;9:e028486. doi: 10.1136/bmjopen-2018-028486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2018-028486</ArticleId><ArticleId IdType="pmc">PMC6549675</ArticleId><ArticleId IdType="pubmed">31152038</ArticleId></ArticleIdList></Reference><Reference><Citation>Khamankar N, Coan G, Weaver B, Mitchell CS. Associative increases in amyotrophic lateral sclerosis survival duration with non-invasive ventilation initiation and usage protocols. Front. Neurol. 2018;9:578. doi: 10.3389/fneur.2018.00578.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.00578</ArticleId><ArticleId IdType="pmc">PMC6052254</ArticleId><ArticleId IdType="pubmed">30050497</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorst J, et al. Effect of high-caloric nutrition on serum neurofilament light chain levels in amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2020;91:1007&#x2013;1009. doi: 10.1136/jnnp-2020-323372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-323372</ArticleId><ArticleId IdType="pubmed">32788256</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph AC, et al. Effect of high-caloric nutrition on survival in amyotrophic lateral sclerosis. Ann. Neurol. 2020;87:206&#x2013;216. doi: 10.1002/ana.25661.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25661</ArticleId><ArticleId IdType="pubmed">31849093</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouteloup C, et al. Hypermetabolism in ALS patients: An early and persistent phenomenon. J. Neurol. 2009;256:1236&#x2013;1242. doi: 10.1007/s00415-009-5100-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-009-5100-z</ArticleId><ArticleId IdType="pubmed">19306035</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyn FJ, et al. Hypermetabolism in ALS is associated with greater functional decline and shorter survival. J. Neurol. Neurosurg. Psychiatry. 2018;89:1016&#x2013;1023. doi: 10.1136/jnnp-2017-317887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-317887</ArticleId><ArticleId IdType="pmc">PMC6166607</ArticleId><ArticleId IdType="pubmed">29706605</ArticleId></ArticleIdList></Reference><Reference><Citation>He J, et al. Hypermetabolism associated with worse prognosis of amyotrophic lateral sclerosis. J. Neurol. 2021 doi: 10.1007/s00415-021-10716-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10716-1</ArticleId><ArticleId IdType="pubmed">34274994</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin B, et al. Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients. J. Neurol. Neurosurg. Psychiatry. 2011;82:628&#x2013;634. doi: 10.1136/jnnp.2010.211474.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.211474</ArticleId><ArticleId IdType="pubmed">21097551</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirk SE, Tracey TJ, Steyn FJ, Ngo ST. Biomarkers of metabolism in amyotrophic lateral sclerosis. Front. Neurol. 2019;10:191. doi: 10.3389/fneur.2019.00191.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00191</ArticleId><ArticleId IdType="pmc">PMC6431787</ArticleId><ArticleId IdType="pubmed">30936848</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson SB, et al. Relationship of creatine kinase to body composition, disease state, and longevity in ALS. Amyotroph. Lateral Scler. Frontotemporal Degener. 2015;16:473&#x2013;477. doi: 10.3109/21678421.2015.1062516.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1062516</ArticleId><ArticleId IdType="pmc">PMC5595062</ArticleId><ArticleId IdType="pubmed">26312548</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikeda K, Hirayama T, Takazawa T, Kawabe K, Iwasaki Y. Relationships between disease progression and serum levels of lipid, urate, creatinine and ferritin in Japanese patients with amyotrophic lateral sclerosis: A cross-sectional study. Intern. Med. 2012;51:1501&#x2013;1508. doi: 10.2169/internalmedicine.51.7465.</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.51.7465</ArticleId><ArticleId IdType="pubmed">22728481</ArticleId></ArticleIdList></Reference><Reference><Citation>Janse van Mantgem MR, et al. Prognostic value of weight loss in patients with amyotrophic lateral sclerosis: A population-based study. J. Neurol. Neurosurg. Psychiatry. 2020;91:867&#x2013;875. doi: 10.1136/jnnp-2020-322909.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-322909</ArticleId><ArticleId IdType="pubmed">32576612</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakayama Y, et al. Body weight variation predicts disease progression after invasive ventilation in amyotrophic lateral sclerosis. Sci. Rep. 2019;9:12262. doi: 10.1038/s41598-019-48831-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-48831-9</ArticleId><ArticleId IdType="pmc">PMC6706382</ArticleId><ArticleId IdType="pubmed">31439899</ArticleId></ArticleIdList></Reference><Reference><Citation>Edens BM, Miller N, Ma YC. Impaired autophagy and defective mitochondrial function: Converging paths on the road to motor neuron degeneration. Front. Cell Neurosci. 2016;10:44. doi: 10.3389/fncel.2016.00044.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2016.00044</ArticleId><ArticleId IdType="pmc">PMC4776126</ArticleId><ArticleId IdType="pubmed">26973461</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu T, et al. The measurement and estimation of total energy expenditure in Japanese patients with ALS: A doubly labelled water method study. Amyotroph. Lateral Scler. Frontotemporal Degener. 2017;18:37&#x2013;45. doi: 10.1080/21678421.2016.1245756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1245756</ArticleId><ArticleId IdType="pubmed">27892703</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradat PF, et al. Impaired glucose tolerance in patients with amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2010;11:166&#x2013;171. doi: 10.3109/17482960902822960.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960902822960</ArticleId><ArticleId IdType="pubmed">20184518</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez De Aguilar JL. Lipid biomarkers for amyotrophic lateral sclerosis. Front. Neurol. 2019;10:284. doi: 10.3389/fneur.2019.00284.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00284</ArticleId><ArticleId IdType="pmc">PMC6458258</ArticleId><ArticleId IdType="pubmed">31019485</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingre C, et al. Lipids, apolipoproteins, and prognosis of amyotrophic lateral sclerosis. Neurology. 2020;94:e1835&#x2013;e1844. doi: 10.1212/WNL.0000000000009322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000009322</ArticleId><ArticleId IdType="pmc">PMC7274849</ArticleId><ArticleId IdType="pubmed">32221024</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks, B. R., Miller, R. G., Swash, M., Munsat, T. L. &amp; Diseases, W. F. O. N. R. G. O. M. N. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord.1, 293&#x2013;299, 10.1080/146608200300079536 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Palange P, et al. Nutritional state and exercise tolerance in patients with COPD. Chest. 1995;107:1206&#x2013;1212. doi: 10.1378/chest.107.5.1206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.107.5.1206</ArticleId><ArticleId IdType="pubmed">7750307</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, et al. The ALSFRS-R: A revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III) J. Neurol. Sci. 1999;169:13&#x2013;21. doi: 10.1016/s0022-510x(99)00210-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-510x(99)00210-5</ArticleId><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Takaoka A, et al. Comparison of energy metabolism and nutritional status of hospitalized patients with Crohn&#x2019;s disease and those with ulcerative colitis. J. Clin. Biochem. Nutr. 2015;56:208&#x2013;214. doi: 10.3164/jcbn.14-95.</Citation><ArticleIdList><ArticleId IdType="doi">10.3164/jcbn.14-95</ArticleId><ArticleId IdType="pmc">PMC4454083</ArticleId><ArticleId IdType="pubmed">26060351</ArticleId></ArticleIdList></Reference><Reference><Citation>Weir JB. New methods for calculating metabolic rate with special reference to protein metabolism. J. Physiol. 1949;109:1&#x2013;9. doi: 10.1113/jphysiol.1949.sp004363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.1949.sp004363</ArticleId><ArticleId IdType="pmc">PMC1392602</ArticleId><ArticleId IdType="pubmed">15394301</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris JA, Benedict FG. A biometric study of human basal metabolism. Proc. Natl. Acad. Sci. U. S. A. 1918;4:370&#x2013;373. doi: 10.1073/pnas.4.12.370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.4.12.370</ArticleId><ArticleId IdType="pmc">PMC1091498</ArticleId><ArticleId IdType="pubmed">16576330</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyake R, et al. Validity of predictive equations for basal metabolic rate in Japanese adults. J. Nutr. Sci. Vitaminol. (Tokyo) 2011;57:224&#x2013;232. doi: 10.3177/jnsv.57.224.</Citation><ArticleIdList><ArticleId IdType="doi">10.3177/jnsv.57.224</ArticleId><ArticleId IdType="pubmed">21908945</ArticleId></ArticleIdList></Reference><Reference><Citation>Desport JC, et al. Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. Am. J. Clin. Nutr. 2001;74:328&#x2013;334. doi: 10.1093/ajcn/74.3.328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/74.3.328</ArticleId><ArticleId IdType="pubmed">11522556</ArticleId></ArticleIdList></Reference><Reference><Citation>Piche T, et al. Resting energy expenditure in chronic hepatitis C. J. Hepatol. 2000;33:623&#x2013;627. doi: 10.1034/j.1600-0641.2000.033004623.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1600-0641.2000.033004623.x</ArticleId><ArticleId IdType="pubmed">11059867</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, et al. Dual-energy X-ray absorptiometry is a valid tool for assessing skeletal muscle mass in older women. J. Nutr. 2007;137:2775&#x2013;2780. doi: 10.1093/jn/137.12.2775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jn/137.12.2775</ArticleId><ArticleId IdType="pubmed">18029498</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa RFD, Masset KVDS, Silva AM, Cabral BGAT, Dantas PMS. Development and cross-validation of predictive equations for fat-free mass and lean soft tissue mass by bioelectrical impedance in Brazilian women. Eur. J. Clin. Nutr. 2021 doi: 10.1038/s41430-021-00946-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41430-021-00946-x</ArticleId><ArticleId IdType="pubmed">34230624</ArticleId></ArticleIdList></Reference><Reference><Citation>McClave SA, et al. Clinical use of the respiratory quotient obtained from indirect calorimetry. JPEN J. Parenter. Enteral Nutr. 2003;27:21&#x2013;26. doi: 10.1177/014860710302700121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/014860710302700121</ArticleId><ArticleId IdType="pubmed">12549594</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanda Y. Investigation of the freely available easy-to-use software &#x2018;EZR&#x2019; for medical statistics. Bone Marrow Transplant. 2013;48:452&#x2013;458. doi: 10.1038/bmt.2012.244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/bmt.2012.244</ArticleId><ArticleId IdType="pmc">PMC3590441</ArticleId><ArticleId IdType="pubmed">23208313</ArticleId></ArticleIdList></Reference><Reference><Citation>Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics. 2000;56:337&#x2013;344. doi: 10.1111/j.0006-341x.2000.00337.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.0006-341x.2000.00337.x</ArticleId><ArticleId IdType="pubmed">10877287</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyn FJ, et al. Altered skeletal muscle glucose-fatty acid flux in amyotrophic lateral sclerosis. Brain Commun. 2020;2:fcaa154. doi: 10.1093/braincomms/fcaa154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa154</ArticleId><ArticleId IdType="pmc">PMC7677608</ArticleId><ArticleId IdType="pubmed">33241210</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu T, et al. Prognostic significance of body weight variation after diagnosis in ALS: A single-centre prospective cohort study. J. Neurol. 2019;266:1412&#x2013;1420. doi: 10.1007/s00415-019-09276-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09276-2</ArticleId><ArticleId IdType="pubmed">30868220</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald KC, et al. Dietary &#x3c9;-3 polyunsaturated fatty acid intake and risk for amyotrophic lateral sclerosis. JAMA Neurol. 2014;71:1102&#x2013;1110. doi: 10.1001/jamaneurol.2014.1214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2014.1214</ArticleId><ArticleId IdType="pmc">PMC4160351</ArticleId><ArticleId IdType="pubmed">25023276</ArticleId></ArticleIdList></Reference><Reference><Citation>Veldink JH, et al. Intake of polyunsaturated fatty acids and vitamin E reduces the risk of developing amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2007;78:367&#x2013;371. doi: 10.1136/jnnp.2005.083378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2005.083378</ArticleId><ArticleId IdType="pmc">PMC2077791</ArticleId><ArticleId IdType="pubmed">16648143</ArticleId></ArticleIdList></Reference><Reference><Citation>Wills AM, et al. Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: A randomised, double-blind, placebo-controlled phase 2 trial. Lancet. 2014;383:2065&#x2013;2072. doi: 10.1016/S0140-6736(14)60222-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)60222-1</ArticleId><ArticleId IdType="pmc">PMC4176708</ArticleId><ArticleId IdType="pubmed">24582471</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L, et al. Prognostic models for amyotrophic lateral sclerosis: A systematic review. J. Neurol. 2021 doi: 10.1007/s00415-021-10508-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10508-7</ArticleId><ArticleId IdType="pubmed">33694050</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>